FDAnews
www.fdanews.com/articles/100669-boston-scientific-sells-cardiac-surgery-vascular-surgery-businesses

Boston Scientific Sells Cardiac Surgery, Vascular Surgery Businesses

November 5, 2007

Boston Scientific has signed an agreement for the sale of its cardiac surgery and vascular surgery businesses to the Getinge Group.

The transaction will be for a cash price of $750 million and is expected to close within the next 45–90 days, Boston Scientific said.

The company announced its intent to sell the cardiac surgery and vascular surgery businesses Aug. 16 as part of its plan to divest nonstrategic assets.